We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

50 hedge funds and large institutions have $38.3M invested in abrdn Life Sciences Investors in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 49 → 50 (+1)

0.99% less ownership

Funds ownership: 12.51% → 11.52% (-0.99%)

12% less capital invested

Capital invested by funds: $43.4M → $38.3M (-$5.09M)

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
+$1.29M
2
CCP
Clough Capital Partners
Massachusetts
+$571K
3
BTS
BB&T Securities
Virginia
+$400K
4
UR
USCA RIA
Texas
+$354K
5
RJA
Raymond James & Associates
Florida
+$277K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$2.6M
2
DA
Doliver Advisors
Texas
-$1.14M
3
LPL Financial
LPL Financial
California
-$937K
4
Citigroup
Citigroup
New York
-$834K
5
AIG
American International Group
New York
-$632K
Name Holding Trade Value Shares
Change 		Change in
Stake
NEPWA
26
New England Private Wealth Advisors
Massachusetts
$205K +$2.66K +144 +1%
UCFA
27
United Capital Financial Advisors
Texas
$185K – – –
Invesco
28
Invesco
Georgia
$183K -$12K -651 -6%
MIC
29
Meridian Investment Counsel
California
$175K – – –
WS
30
Wedbush Securities
California
$174K +$186K +10,104 New
MFS
31
MSI Financial Services
Massachusetts
$153K -$90.1K -4,881 -35%
Creative Planning
32
Creative Planning
Kansas
$150K -$34.1K -1,850 -18%
IA
33
IFP Advisors
Florida
$107K -$32K -1,735 -22%
Citigroup
34
Citigroup
New York
$98K -$834K -45,191 -89%
VNA
35
Valley National Advisers
Pennsylvania
$56K – – –
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
$33K -$22K -1,193 -38%
ASN
37
Advisory Services Network
Georgia
$24K +$24.4K +1,324 +1,865%
NSIM
38
North Star Investment Management
Illinois
$21K +$406 +22 +2%
Northwestern Mutual Wealth Management
39
Northwestern Mutual Wealth Management
Wisconsin
$18K +$849 +46 +5%
NFG
40
Next Financial Group
Texas
$16K -$2.49K -135 -13%
SIA
41
SeaBridge Investment Advisors
New Jersey
$16K – – –
MSFP
42
Mark Sheptoff Financial Planning
Connecticut
$11K – – –
BC
43
Barnett & Company
Tennessee
$9K – – –
AIM
44
Arcadia Investment Management
Michigan
$7K – – –
Deutsche Bank
45
Deutsche Bank
Germany
$5K +$258 +14 +5%
TJHA
46
Thomas J. Herzfeld Advisors
Florida
$1K +$18 +1 +2%
BAM
47
Bruderman Asset Management
New York
$1K +$646 +35 New
AIG
48
American International Group
New York
– -$632K -35,249 Closed
GC
49
Guggenheim Capital
Illinois
– -$371K -20,664 Closed
US Bancorp
50
US Bancorp
Minnesota
– -$31K -1,741 Closed
1
2
3

HQL Hedge Fund Activity: Q2 2016 in Review

50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2016, worth a combined $38.3M — down 12% from $43.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HQL positions and 7 closed out — a net gain of 1 holder — while 15 added to existing stakes and 18 trimmed.

The largest buyer was Stifel Financial, opening a new position worth an estimated $1.29M. The largest seller was Morgan Stanley, cutting an estimated $2.6M.

  • 50 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2016, up from 49 in Q1 2016.
  • Funds reported $38.3M of abrdn Life Sciences Investors stock for Q2 2016, down 12% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q2 2016 and 7 closed out, a net change of +1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q2 2016 was Stifel Financial, an estimated $1.29M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2016 was Morgan Stanley, an estimated $2.6M sold.

Based on aggregated 13F filings for Q2 2016.